220 related articles for article (PubMed ID: 1730031)
81. Inhibitory effect of staphylokinase on platelet aggregation.
Suehiro A; Oura Y; Ueda M; Kakishita E
Thromb Haemost; 1993 Nov; 70(5):834-7. PubMed ID: 7510426
[TBL] [Abstract][Full Text] [Related]
82. Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin.
Turner RB; Liu L; Sazonova IY; Reed GL
J Biol Chem; 2002 Sep; 277(36):33068-74. PubMed ID: 12080056
[TBL] [Abstract][Full Text] [Related]
83. Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin.
Ichinose A; Tamaki T; Aoki N
FEBS Lett; 1983 Mar; 153(2):369-71. PubMed ID: 6617867
[TBL] [Abstract][Full Text] [Related]
84. On the role of the carbohydrate side chains of human plasminogen in its interaction with alpha 2-antiplasmin and fibrin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1981 Nov; 120(1):149-54. PubMed ID: 7308211
[No Abstract] [Full Text] [Related]
85. Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1984 Nov; 144(3):541-4. PubMed ID: 6489341
[TBL] [Abstract][Full Text] [Related]
86. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
Nesheim M; Fredenburgh JC; Larsen GR
J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
[TBL] [Abstract][Full Text] [Related]
87. Structural domains of streptokinase involved in the interaction with plasminogen.
Rodríguez P; Fuentes P; Barro M; Alvarez JG; Muñoz E; Collen D; Lijnen HR
Eur J Biochem; 1995 Apr; 229(1):83-90. PubMed ID: 7744053
[TBL] [Abstract][Full Text] [Related]
88. Integration of VEK-30 peptide enhances fibrinolytic properties of staphylokinase.
Bhando T; Singh S; Hade MD; Kaur J; Dikshit KL
Biotechnol Appl Biochem; 2021 Apr; 68(2):213-220. PubMed ID: 32233032
[TBL] [Abstract][Full Text] [Related]
89. Thrombolytic properties of staphylokinase.
Matsuo O; Okada K; Fukao H; Tomioka Y; Ueshima S; Watanuki M; Sakai M
Blood; 1990 Sep; 76(5):925-9. PubMed ID: 2118398
[TBL] [Abstract][Full Text] [Related]
90. On the mechanism of the activation of human plasminogen by recombinant staphylokinase.
Collen D; Schlott B; Engelborghs Y; Van Hoef B; Hartmann M; Lijnen HR; Behnke D
J Biol Chem; 1993 Apr; 268(11):8284-9. PubMed ID: 8463338
[TBL] [Abstract][Full Text] [Related]
91. Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion.
Nedaeinia R; Faraji H; Javanmard SH; Ferns GA; Ghayour-Mobarhan M; Goli M; Mashkani B; Nedaeinia M; Haghighi MHH; Ranjbar M
Mol Biol Rep; 2020 Jan; 47(1):819-841. PubMed ID: 31677034
[TBL] [Abstract][Full Text] [Related]
92. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase.
Mölkänen T; Tyynelä J; Helin J; Kalkkinen N; Kuusela P
FEBS Lett; 2002 Apr; 517(1-3):72-8. PubMed ID: 12062412
[TBL] [Abstract][Full Text] [Related]
93. Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactions.
Gladysheva IP; Sazonova IY; Chowdhry SA; Liu L; Turner RB; Reed GL
J Biol Chem; 2002 Jul; 277(30):26846-51. PubMed ID: 12016220
[TBL] [Abstract][Full Text] [Related]
94. A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo.
Holvoet P; Lijnen HR; Collen D
J Biol Chem; 1985 Oct; 260(22):12106-11. PubMed ID: 2413020
[TBL] [Abstract][Full Text] [Related]
95. Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin.
Ichinose A; Mimuro J; Koide T; Aoki N
Thromb Res; 1984 Feb; 33(4):401-7. PubMed ID: 6710439
[TBL] [Abstract][Full Text] [Related]
96. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
Kimura S; Aoki N
J Biol Chem; 1986 Nov; 261(33):15591-5. PubMed ID: 2877981
[TBL] [Abstract][Full Text] [Related]
97. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
Christensen U; Bangert K; Thorsen S
FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
[TBL] [Abstract][Full Text] [Related]
98. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.
Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P
BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118
[TBL] [Abstract][Full Text] [Related]
99. Location of plasminogen-binding sites in human fibrin(ogen).
Váradi A; Patthy L
Biochemistry; 1983 May; 22(10):2440-6. PubMed ID: 6222763
[TBL] [Abstract][Full Text] [Related]
100. Species specificity in the acceleration of tissue-type plasminogen activator-mediated activation of plasminogens, by fibrinogen cyanogen bromide fragments.
Nieuwenhuizen W; Keyser J
Thromb Res; 1985 Jun; 38(6):663-70. PubMed ID: 4040660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
